HYLEUKIN-7

EUIPO EUIPO 2019 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark HYLEUKIN-7 was filed as Word mark on 06/12/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/09/2020. The current status of the mark is "Trademark registered".

Trademark Details Last update: January 26, 2022

Trademark form Word mark
File reference 018080957
Application date June 12, 2019
Publication date September 17, 2019
Entry date January 9, 2020
Expiration date June 12, 2029

Trademark owner

4th fl., Bldg B, Korea Bio Park, 700, Daewangpangyo-ro, Bundang-gu
13488 Seongnam-si, Gyeonggi-do
KR

Trademark representatives

C/ Fernández de la Hoz, 33, 4º CI 28010 Madrid ES

goods and services

5 Pharmaceuticals; Vaccines; Anti-cancer preparations; Antibiotics; Antibiotic preparations; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of inflammatory diseases; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting digestive organs; Dermatological pharmaceutical products; Plasma (Blood -); Pharmaceutical agents affecting metabolism; Anti-inflammatory preparations; Disinfectants for hygiene purposes; Fungicides; Medicated candy; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diabetes; Preparations for the treatment of asthma; Elixirs for psoriasis; Immunoglobulin fusion protein agents for medical use; Pharmaceutical preparations for treating neutropenia; Pharmaceutical preparations for treating anemia; Pharmaceutical preparations for treating dwarfism; Pharmaceutical preparations for treating inflammatory bowel disease; Pharmaceutical preparations for treating short-bowel syndrome; Pharmaceutical preparations for treating proliferative arthritis; Pharmaceutical preparations for treating systemic lupus erythematosus; Pharmaceutical preparations for treating cervical tumor; Pharmaceutical preparations for the treatment of lymphopenia; Immunoglobulin fusion protein preparation for medical use

Trademark history

Date Document number Area Entry
January 25, 2022 Change Representative, Published

ID: 11018080957